Yield10 Bioscience, Inc. Stock
Stocks
YTENQ
US98585K8541
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
0.00% | - |
| 25-10-31 | Yield10 Bioscience, Inc. Went Out of Business | CI |
| 25-10-14 | First Amended Joint Liquidation Plan Approved for Yield10 Bioscience, Inc. | CI |
| Market Cap | 229K 201K 187K 172K 323K 21.89M 328K 2.22M 870K 10.86M 860K 842K 37.51M | P/E 2022 |
-0.6x | P/E 2023 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 2.34M 2.05M 1.91M 1.76M 3.3M 223M 3.35M 22.68M 8.88M 111M 8.78M 8.59M 383M | EV / Sales 2022 |
14.6x | EV / Sales 2023 | 83x |
| Free-Float |
86% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -99.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 54.48 |
| 5 years | 0 | | 210.24 |
| 10 years | 0 | | 8,927.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
CEO | Chief Executive Officer | 68 | 2016-10-16 |
Charles Haaser
DFI | Director of Finance/CFO | 70 | 2014-11-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
BRD | Director/Board Member | 68 | 2009-07-06 |
| Chairman | 69 | 2011-11-07 | |
Richard Hamilton
BRD | Director/Board Member | 63 | 2017-03-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/15/24 | Tax | Chief Financial Officer | 731 | 0.1138% | ||
| 8/15/24 | Tax | Founder | 1,463 | 0.2277% | ||
| 8/15/24 | Tax | Chief Technology Officer | 877 | 0.1365% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | 0.00% | - | - | 0 | |
| +0.14% | -0.67% | -0.88% | +11.02% | 47.74B | |
| -2.58% | -0.80% | +387.98% | +607.20% | 39.98B | |
| +0.98% | +2.95% | +11.41% | +45.74% | 36.23B | |
| +13.06% | +18.28% | +20.59% | +5.45% | 35.59B | |
| -0.73% | +2.78% | +4.65% | +41.16% | 27.91B | |
| -0.96% | -2.11% | - | - | 16.71B | |
| -2.53% | +8.04% | +26.79% | +125.44% | 16.45B | |
| +2.39% | -1.64% | +4.74% | +9.95% | 13.21B | |
| +7.29% | +7.97% | -5.15% | -28.65% | 12.93B | |
| Average | -8.20% | +2.50% | +56.26% | +102.16% | 24.68B | |
| Weighted average by Cap. | +1.85% | +2.95% | +74.69% | +128.79% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 450K 395K 368K 338K 634K 42.99M 645K 4.36M 1.71M 21.32M 1.69M 1.65M 73.66M | 60K 52.66K 49.03K 45.1K 84.54K 5.73M 85.99K 582K 228K 2.84M 225K 220K 9.82M |
| Net income | -13.57M -11.91M -11.09M -10.2M -19.12M -1.3B -19.44M -132M -51.48M -643M -50.93M -49.83M -2.22B | -14.46M -12.69M -11.81M -10.87M -20.37M -1.38B -20.72M -140M -54.86M -685M -54.27M -53.09M -2.37B |
| Net Debt | -1.7M -1.49M -1.39M -1.28M -2.39M -162M -2.43M -16.45M -6.44M -80.4M -6.37M -6.23M -278M | 2.11M 1.85M 1.72M 1.59M 2.97M 202M 3.02M 20.46M 8.01M 99.97M 7.92M 7.75M 345M |
Employees
29
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YTENQ Stock
Select your edition
All financial news and data tailored to specific country editions
